{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:30:05Z","timestamp":1790505005756,"version":"4.1.0"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.45319","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:31:13Z","timestamp":1643369473000},"page":"e2145319","source":"Crossref","is-referenced-by-count":45,"title":["Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment"],"prefix":"10.1001","volume":"5","author":[{"given":"Zachary A.","family":"Marcum","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana B.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine G.","family":"Derington","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H.","family":"Greene","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Ghazi","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Accelerator, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Herrick","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"},{"name":"George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan B.","family":"King","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"},{"name":"George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah"},{"name":"Institute for Health Research, Kaiser Permanente Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred K.","family":"Cheung","sequence":"additional","affiliation":[{"name":"George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah"},{"name":"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Bryan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Supiano","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Sonnen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Neurology and Neurosurgery, McGill University School of Medicine, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Weintraub","sequence":"additional","affiliation":[{"name":"MedStar Health Research Institute and Georgetown University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Williamson","sequence":"additional","affiliation":[{"name":"Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Pajewski","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Bress","sequence":"additional","affiliation":[{"name":"Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City"},{"name":"George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah"},{"name":"Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Systolic Blood Pressure Intervention Trial (SPRINT) Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"10248","key":"zoi211253r1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"zoi211253r4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi211253r5","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1212\/WNL.0000000000010996","article-title":"Association of angiotensin II\u2013stimulating antihypertensive use and dementia risk: post hoc analysis of the PreDIVA trial.","volume":"96","author":"van Dalen","year":"2021","journal-title":"Neurology"},{"issue":"3","key":"zoi211253r6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"zoi211253r7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1136\/hrt.2006.107706","article-title":"Renin: friend or foe?","volume":"93","author":"Brown","year":"2007","journal-title":"Heart"},{"key":"zoi211253r8","author":"Kaschina","year":"2017"},{"issue":"3","key":"zoi211253r9","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology.","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"issue":"7-8","key":"zoi211253r10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10571-006-9009-0","article-title":"Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain.","volume":"26","author":"Saavedra","year":"2006","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"zoi211253r11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1476-5381.2010.01167.x","article-title":"Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.","volume":"163","author":"Horiuchi","year":"2011","journal-title":"Br J Pharmacol"},{"key":"zoi211253r12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neubiorev.2018.05.005","article-title":"Cognitive benefits of angiotensin IV and angiotensin-(1-7): a systematic review of experimental studies.","volume":"92","author":"Ho","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"zoi211253r13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10571-015-0285-4","article-title":"Neurovascular and cognitive failure in Alzheimer\u2019s disease: benefits of cardiovascular therapy.","volume":"36","author":"Hamel","year":"2016","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"zoi211253r14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2174\/1567205012666141218140953","article-title":"Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer\u2019s disease.","volume":"12","author":"Baranello","year":"2015","journal-title":"Curr Alzheimer Res"},{"issue":"2-3","key":"zoi211253r15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0167-0115(01)00312-3","article-title":"A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits.","volume":"102","author":"Pederson","year":"2001","journal-title":"Regul Pept"},{"issue":"10","key":"zoi211253r16","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1523\/JNEUROSCI.19-10-03952.1999","article-title":"Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning.","volume":"19","author":"Wright","year":"1999","journal-title":"J Neurosci"},{"key":"zoi211253r17","doi-asserted-by":"publisher","first-page":"A069","DOI":"10.1161\/hyp.72.suppl_1.069","article-title":"Antihypertensive medication treatment regimens in SPRINT.","volume":"72","author":"King","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"zoi211253r18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"22","key":"zoi211253r19","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi211253r20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000089515","article-title":"Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors.","volume":"21","author":"Ravaglia","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"zoi211253r21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/archpsyc.63.8.916","article-title":"Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.","volume":"63","author":"Tabert","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"zoi211253r22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000095427","article-title":"Subtype of mild cognitive impairment and progression to dementia and death.","volume":"22","author":"Yaffe","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"zoi211253r23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/01.wnl.0000252358.03285.9d","article-title":"Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.","volume":"68","author":"Fischer","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"zoi211253r24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1017\/S1041610209990792","article-title":"Diagnostic transitions in mild cognitive impairment subtypes.","volume":"21","author":"Forlenza","year":"2009","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"zoi211253r25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jnnp.2008.171066","article-title":"Two-year outcome of MCI subtypes and aetiologies in the G\u00f6teborg MCI study.","volume":"81","author":"Nordlund","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"zoi211253r26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/S1041610211002870","article-title":"The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer\u2019s dementia and vascular dementia.","volume":"24","author":"Jungwirth","year":"2012","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"zoi211253r27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000339159","article-title":"Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer\u2019s disease.","volume":"33","author":"Lee","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1-2","key":"zoi211253r28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000348354","article-title":"Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer\u2019s disease in the European prospective DESCRIPA study.","volume":"36","author":"Damian","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"zoi211253r29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1037\/a0028576","article-title":"Neuropsychological measures predict decline to Alzheimer\u2019s dementia from mild cognitive impairment.","volume":"26","author":"Summers","year":"2012","journal-title":"Neuropsychology"},{"issue":"4","key":"zoi211253r30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/jgs.12742","article-title":"Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer\u2019s disease.","volume":"62","author":"Julayanont","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"zoi211253r31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3233\/JAD-150625","article-title":"Prognostic significance of mild cognitive impairment subtypes for dementia and mortality: data from the NEDICES cohort.","volume":"50","author":"Bermejo-Pareja","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"zoi211253r32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi211253r33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","article-title":"A weighting analogue to pair matching in propensity score analysis.","volume":"9","author":"Li","year":"2013","journal-title":"Int J Biostat"},{"issue":"3","key":"zoi211253r34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies.","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"12A","key":"zoi211253r35","doi-asserted-by":"crossref","first-page":"112i","DOI":"10.1016\/j.amjcard.2007.03.029","article-title":"The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods.","volume":"99","author":"Williamson","year":"2007","journal-title":"Am J Cardiol"},{"issue":"8","key":"zoi211253r36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12252","article-title":"Effects of candesartan vs lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: a randomized clinical trial.","volume":"3","author":"Hajjar","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"23","key":"zoi211253r37","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"zoi211253r38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"issue":"3","key":"zoi211253r39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/WAD.0000000000000252","article-title":"Baseline amnestic severity predicts progression from amnestic mild cognitive impairment to Alzheimer disease dementia at 3 years.","volume":"32","author":"Bradfield","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"11","key":"zoi211253r40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25127","article-title":"Association of race\/ethnicity-specific changes in antihypertensive medication classes initiated among Medicare beneficiaries with the eighth Joint National Committee Panel Member Report.","volume":"3","author":"Colvin","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi211253r41","first-page":"329","article-title":"Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors.","volume":"57","author":"Faure","year":"2006","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"zoi211253r42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuropharm.2006.05.029","article-title":"Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress.","volume":"51","author":"Hamai","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1","key":"zoi211253r43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1291\/hypres.31.161","article-title":"Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice.","volume":"31","author":"Iwai","year":"2008","journal-title":"Hypertens Res"},{"issue":"7","key":"zoi211253r44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"zoi211253r45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2003.12.006","article-title":"Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.","volume":"124","author":"Lee","year":"2004","journal-title":"Neuroscience"},{"issue":"6","key":"zoi211253r46","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J"},{"issue":"17","key":"zoi211253r47","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1097\/01.wnr.0000187636.13147.cd","article-title":"Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats.","volume":"16","author":"Lu","year":"2005","journal-title":"Neuroreport"},{"issue":"11","key":"zoi211253r48","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain \u00df-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"issue":"8","key":"zoi211253r49","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1097\/HJH.0b013e32814a5ae5","article-title":"Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? a meta-analysis of trials according to treatment with potentially different effects on angiotensin II.","volume":"25","author":"Boutitie","year":"2007","journal-title":"J Hypertens"},{"issue":"4","key":"zoi211253r50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1592\/phco.25.4.531.61022","article-title":"Can the renin-angiotensin system protect against stroke? a focus on angiotensin II receptor blockers.","volume":"25","author":"Epstein","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"12","key":"zoi211253r51","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","article-title":"Impact of angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.","volume":"69","author":"Hajjar","year":"2012","journal-title":"Arch Neurol"},{"issue":"9","key":"zoi211253r52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaneurol.2015.1001","article-title":"Association between angiotensin receptor blockers and longitudinal decline in tau in mild cognitive impairment.","volume":"72","author":"Hajjar","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"zoi211253r53","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3317\/jraas.2006.027","article-title":"Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV.","volume":"7","author":"Braszko","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"3-4","key":"zoi211253r54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0891-0618(00)00112-5","article-title":"Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography.","volume":"20","author":"Chai","year":"2000","journal-title":"J Chem Neuroanat"},{"issue":"2-3","key":"zoi211253r55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0167-0115(98)00028-7","article-title":"Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog.","volume":"74","author":"Pederson","year":"1998","journal-title":"Regul Pept"},{"issue":"3","key":"zoi211253r56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease.","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"1","key":"zoi211253r57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40478-019-0718-2","article-title":"Divergence in the activity of the N- and C- catalytic domains of ACE1\u2014implications for the role of the renin-angiotensin system in Alzheimer\u2019s disease.","volume":"7","author":"Al Mulhim","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"zoi211253r2","year":"2017"},{"key":"zoi211253r3","unstructured":"Centers for Disease Control and Prevention. Facts about hypertension. Accessed August 11, 2021. https:\/\/www.cdc.gov\/bloodpressure\/facts.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2788465\/marcum_2022_oi_211253_1642641831.32596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T11:31:26Z","timestamp":1643369486000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2788465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.45319","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741530655.793591334","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]}}}